Fuzhou University Affiliated Provincial Hospital | China
Author Profile
Scopus
Orcid ID
🎓 THE REMARKABLE JOURNEY OF FU-SHAN XUE: A TRAILBLAZER IN ANESTHESIOLOGY
🎓 EARLY ACADEMIC PURSUITS
Fu-Shan Xue’s academic journey laid a strong foundation for his outstanding future career. His deep passion for medical sciences, particularly anesthesiology and surgery, led him to pursue rigorous academic training, culminating in his appointment as a Doctoral Supervisor. His dedication during his formative academic years built the groundwork for his later roles as a Chief Physician and Distinguished Professor at Beijing Anzhen Hospital, Capital Medical University.
🏥 PROFESSIONAL ENDEAVORS
Dr. Xue’s professional career is marked by exceptional achievements and prestigious appointments. Serving as the Chief Physician and Professor at the Anesthesiology and Surgery Center of Beijing Anzhen Hospital, he became one of the leading figures in the field. Beyond his hospital responsibilities, he has been recognized as:
-
National Candidate of the "New Century Millions of Talents Project",
-
Expert with Special Allowance of the State Council,
-
Young and Middle-Aged Expert with Outstanding National Contributions,
-
Leading Talent of the National "Ten-Thousand Talents Program".
These distinctions reflect his national and international stature as a pioneering anesthesiologist.
📚 CONTRIBUTIONS AND RESEARCH FOCUS ON CLINICAL MEDICINE
Dr. Xue has significantly advanced the field of anesthesiology through his extensive research and innovation. His focus spans various critical areas, including:
-
Innovative techniques in anesthesia and perioperative medicine,
-
Enhancing patient safety during surgical procedures,
-
Developing new surgical and anesthetic methodologies.
His contributions have led to real-world advancements in clinical practices, making surgeries safer and improving patient outcomes.
🌍 IMPACT AND INFLUENCE
The impact of Dr. Xue’s work extends far beyond the walls of his institution:
-
Published more than 1,180 academic papers, including over 830 as the first and corresponding author in SCI-indexed journals,
-
Edited and translated 15 professional books that serve as key references in the field,
-
Achieved 86 national patents (including 11 invention patents) and 10 foreign patents,
-
Honored with 8 prestigious awards at the provincial and ministerial levels.
Dr. Xue’s influence resonates through medical education, research innovation, and clinical excellence in China and globally.
📈 ACADEMIC CITATIONS
Given his prolific research output, Dr. Xue’s work has been widely cited across national and international medical communities. His extensive citation record demonstrates the foundational importance of his research in advancing anesthesiology and surgery disciplines. He stands as a major reference point for upcoming anesthesiologists and researchers worldwide.
🏆 LEGACY AND FUTURE CONTRIBUTIONS
Fu-Shan Xue’s legacy is already deeply entrenched in the history of anesthesiology:
-
A pioneer in bridging clinical practice and innovative research,
-
A mentor to new generations of physicians and researchers,
-
An architect of safer and more effective anesthesia practices.
Looking ahead, Dr. Xue continues to drive cutting-edge innovations, pursue international collaborations, and mentor young talents. His future contributions are expected to further revolutionize perioperative medicine, enhance global surgical standards, and inspire countless young professionals to follow in his footsteps.
🏅 AWARDS AND HONORS
-
China Distinguished Research Award of Anaesthesia
-
China Distinguishable Anaesthetist Award
-
Wu Yang Medical Medicine Award
-
Nie Jiedong Medical Award
-
Health Defender of Healthy China
-
Top 10 Innovative Medical Experts
These accolades underscore his unparalleled contributions to the advancement of medical science and patient care.
📑NOTABLE PUBLICATIONS
"The UCP2/PINK1/LC3b-mediated mitophagy is involved in the protection of NRG1 against myocardial ischemia/reperfusion injury"
- Authors: X., Li, Xintao , X., Li, Xinyue , T., Tian, Tian , M., Jin, Mu , F., Xue, Fushan
- Journal: Redox Biology
- Year: 2025
"Esketamine at a Clinical Dose Attenuates Cerebral Ischemia/Reperfusion Injury by Inhibiting AKT Signaling Pathway to Facilitate Microglia M2 Polarization and Autophagy"
- Authors: Y., Gao, Ying , L., Li, Lu , F., Zhao, Fang , M., Jin, Mu , F., Xue, Fushan
- Journal: Drug Design, Development and Therapy
- Year: 2025
"Subglottic airway injury during fiberscope-monitored intubation with a supraglottic airway device: A randomized controlled comparison of three tracheal tubes"
- Authors: K., Su, Kai , S., Xu, Shangjun , H., Wang, Haixia , F., Xue, Fushan , M., Tian
- Journal: Ming Chinese Medical Journal
- Year: 2025